Jason Novak focuses his practice on intellectual property transactions, diligence, procurement and portfolio management for clients in the personalized/precision medicine (e.g., genomic sequencing platforms, computational genomics/bioinformatics, molecular diagnostics, etc.), digital health, life sciences tooling (e.g., qPCR, dPCR, capillary electrophoresis, etc.), medical device and food industries. He has extensive experience in intellectual property strategy and patent portfolio management, preparation and prosecution, oppositions, counseling, licensing and technology transactions, in and out-licensing, freedom-to-operate, various types of due diligence, IP training, risk recognition and management, and dispute resolution.
Before transitioning to the legal industry, Jason was the Director IP Counsel for a multinational, biotechnology product development company. He managed worldwide intellectual property needs in genetic sciences instrumentation and software. Additionally, Jason was a research engineer for a leading food product company, where he led numerous product and process redesigns, reformulations and commercializations. This previous experience has attributed to his knowledge in dealing with various corporate functions from both an R&D and legal perspective.